Lv7
5005 积分 2021-03-15 加入
Allogeneic hematopoietic cell transplantation for acute myeloid leukemia in adults over 70 years old
1个月前
已完结
Pre-emptive therapeutic decisions based on measurable residual disease status in acute myeloid leukemia: ready for prime time?
1个月前
已完结
How I treat AML relapse after allogeneic HSCT
1个月前
已完结
Measurable residual disease-guided interventions in patients with acute myeloid leukaemia undergoing allogeneic haematopoietic cell transplantation: best practice recommendations from the European Society for Blood and Marrow Transplantation Practice Harmonisation and Guidelines Committee
1个月前
已完结
Tailoring Intensity: A Perspective on Thiotepa, Busulfan and Fludarabine (TBF) Conditioning for Acute Leukemias and Myeloproliferative Neoplasms
1个月前
已完结
Myelodysplastic syndromes versus acute myeloid leukaemia: biology or blasts—what truly defines the disease and does it matter?
1个月前
已完结
Advancing chronic myeloid leukemia research with next-generation sequencing: potential benefits, limitations, and future clinical integration
1个月前
已完结
How I approach hematopoietic stem cell transplantation for CML in a TKI world
1个月前
已完结
How I evaluate and treat resistance and relapse in CML
1个月前
已完结
How I manage chronic myeloid leukemia during pregnancy
1个月前
已完结
皖公网安备34019202002308
